Marion Arnaud-Menozzi
Geneve, GE 1218, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Improving the Suitability of Vaccine Design for Immunisation Programmes and Enhancing Vaccine Policy Quality Through User Research.
Journal: Vaccines
Published: July 16, 2025
An Application of an Initial Full Value of Vaccine Assessment Methodology to Measles-Rubella MAPs for Use in Low- and Middle-Income Countries.
Journal: Vaccines
Published: August 14, 2024
A review of potential use cases for measles-rubella, measles-mumps-rubella, and typhoid-conjugate vaccines presented on microarray patches.
Journal: Vaccine
Published: June 16, 2023
Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification.
Journal: Frontiers in public health
Published: February 13, 2023
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.
Journal: Expert opinion on drug delivery
Published: January 17, 2023
Estimating the future global dose demand for measles-rubella microarray patches.
Journal: Frontiers in public health
Published: September 05, 2022
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges.
Journal: Frontiers in public health
Published: November 05, 2021
Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries.
Journal: Vaccine
Published: May 10, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026